Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OPERATING INCOME
Operating Income HALO - Halozyme Therapeutics, Inc.
338 M
LAST VALUE
10.61%
2 YEAR CAGR
47.02%
5 YEAR CAGR
20.01%
10 YEAR CAGR